Page last updated: 2024-10-26

doxapram and Pulmonary Hypertension

doxapram has been researched along with Pulmonary Hypertension in 2 studies

Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flenley, DC1
Bisgard, GE1
Ruiz, AV1
Grover, RF1
Will, JA1

Other Studies

2 other studies available for doxapram and Pulmonary Hypertension

ArticleYear
Methods and results of assessing the hypoxic ventilatory drive in patients and normal subjects.
    Bulletin europeen de physiopathologie respiratoire, 1979, Volume: 15 Suppl

    Topics: Bronchitis; Carbon Dioxide; Chemoreceptor Cells; Chronic Disease; Diabetic Neuropathies; Doxapram; H

1979
Ventilatory acclimatization to 3400 meters altitude in the Hereford calf.
    Respiration physiology, 1974, Volume: 21, Issue:3

    Topics: Acclimatization; Altitude; Animals; Bicarbonates; Biological Transport; Carbon Dioxide; Cardiac Outp

1974